Surginex
- Biotech or pharma, therapeutic R&D
Surginex. Next Gen LNP Platform
• We develop patented ionizable lipids for vaccines and therapeutics with low toxicity and high efficiency.
• Our LNPs enable repeated dosing, and support the delivery of various genetic payloads, including ASOs, siRNAs, mRNAs, and gene editors.
• By modulating surface charge, our LNPs can achieve targeted delivery not only to the liver but also to the lung, spleen, kidney, and muscle tissues.
• We seek partners for collaboration and licensing to advance lipid-based drug delivery.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}